- Home
- A-Z Publications
- Current Physical Chemistry
- Previous Issues
- Volume 13, Issue 1, 2023
Current Physical Chemistry - Volume 13, Issue 1, 2023
Volume 13, Issue 1, 2023
-
-
A Review on the Synthesis and Pharmacological Activity of Heterocyclic Compounds
Authors: Jyoti Baranwal, Smriti Kushwaha, Swastika Singh and Archana JyotiBiologically active compounds play a very important role in our daily life. Almost all biologically active compounds contain heteroatoms and among these, a major portion is heterocycles. Heterocycles are a significant component in drug development programs. Drugs containing a heterocyclic moiety are highly valued resources in the fight against human and animal diseases. Some of these compounds are utilized as anticonvul Read More
-
-
-
Meloxicam Performances for Copper Corrosion Inhibition in 1M HNO3: Experimental and Theoretical Approaches
Background: Copper is a metal that is widely used in many fields such as industry and construction, etc. These different industrial sectors use acid solutions such as nitric acid and hydrochloric acid, etc. The use of acid solutions in the industrial environment causes degradation of materials. In recent decades, the use of corrosion inhibitors has become very essential. Objective: The objective of our study is to test the performan Read More
-
-
-
DFT and Molecular Docking Analysis of Newly Synthesized Compound (2E)-3-[3-(Benzyloxy) Phenyl]-1-(4’-Chlorophe-Nyl)- 2-Propen-1-One [Bpclpo]
Background: The parent molecule in the skeleton of this chalcone is the benzyloxy phenyl, which is linked to the chlorophenylpropen at C-3. The hydrophobic phenyl groups are naturally resistant to oxidation and reduction. Antiviral, antimalarial, antibacterial, anti-inflammatory, anticancer, antioxidant, antitubercular, and anti-Alzheimer activities are among the many pharmacological properties of chalcone derivatives. As a r Read More
-
-
-
Antiparkinsonian Potential of Natural Products: Molecular Docking, Prediction of Pharmacokinetic and Toxicological Properties
Background: Parkinson's disease (PD) is a neurodegenerative pathology common in the elderly, and it may be related to several factors, such as excessive and continuous use of drugs, alcoholism, and cerebral ischemia, among others. Emphasizing that there is still no cure for PD, current pharmacological treatment aims to restore reduced dopaminergic activity in the central nervous system and manage symptoms. Howe Read More
-
Most Read This Month
Article
content/journals/cpc
Journal
10
5
false
en
